BioLineRx (BLRX) Tops Q3 EPS by 15c
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.01), $0.15 better than the analyst estimate of ($0.16).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.01), $0.15 better than the analyst estimate of ($0.16).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.